Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics.
An analysis of the uncertainty in guidelines for the ingestion of methylmercury (MeHg) due to human pharmacokinetic variability was conducted using a physiologically based pharmacokinetic (PBPK) model that describes MeHg kinetics in the pregnant human and fetus. Two alternative derivations of an ingestion guideline for MeHg were considered: the U.S. Environmental Protection Agency reference dose (RfD) of 0.1 microgram/kg/day derived from studies of an Iraqi grain poisoning episode, and the Agency for Toxic Substances and Disease Registry chronic oral minimal risk level (MRL) of 0.5 microgram/kg/day based on studies of a fish-eating population in the Seychelles Islands. Calculation of an ingestion guideline for MeHg from either of these epidemiological studies requires calculation of a dose conversion factor (DCF) relating a hair mercury concentration to a chronic MeHg ingestion rate. To evaluate the uncertainty in this DCF across the population of U.S. women of child-bearing age, Monte Carlo analyses were performed in which distributions for each of the parameters in the PBPK model were randomly sampled 1000 times. The 1st and 5th percentiles of the resulting distribution of DCFs were a factor of 1.8 and 1.5 below the median, respectively. This estimate of variability is consistent with, but somewhat less than, previous analyses performed with empirical, one-compartment pharmacokinetic models. The use of a consistent factor in both guidelines of 1.5 for pharmacokinetic variability in the DCF, and keeping all other aspects of the derivations unchanged, would result in an RfD of 0.2 microgram/kg/day and an MRL of 0.3 microgram/kg/day.
Clewell
H J
HJ
K.S. Crump Group, Inc., ICF Kaiser International, Ruston, Louisiana 71270, USA.
Gearhart
J M
JM
Gentry
P R
PR
Covington
T R
TR
VanLandingham
C B
CB
Crump
K S
KS
Shipp
A M
AM
D000328:Adult; D005260:Female; D006197:Hair / Q000378:metabolism; D006801:Humans; D008297:Male; D008767:Methylmercury Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000506:poisoning; D008954:Models, Biological; D009010:Monte Carlo Method; D019055:No-Observed-Adverse-Effect Level; D011247:Pregnancy; D018570:Risk Assessment
D008767:Methylmercury Compounds